Neurocrine Biosciences, Inc. (NBIX)
166.09
+1.24
(+0.75%)
USD |
NASDAQ |
Nov 04, 16:00
166.94
+0.85
(+0.51%)
After-Hours: 18:52
Neurocrine Biosciences Total Return Price : 166.09 for Nov. 4, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| November 03, 2026 | 164.85 |
| November 02, 2026 | 145.35 |
| October 30, 2026 | 146.10 |
| October 29, 2026 | 146.38 |
| October 28, 2026 | 145.53 |
| October 27, 2026 | 146.00 |
| October 26, 2026 | 145.87 |
| October 23, 2026 | 142.70 |
| October 22, 2026 | 143.29 |
| October 21, 2026 | 141.31 |
| October 20, 2026 | 142.00 |
| October 19, 2026 | 136.98 |
| October 16, 2026 | 135.71 |
| October 15, 2026 | 136.95 |
| October 14, 2026 | 135.91 |
| October 13, 2026 | 135.13 |
| October 12, 2026 | 141.37 |
| October 09, 2026 | 142.44 |
| October 08, 2026 | 141.25 |
| October 07, 2026 | 143.47 |
| October 06, 2026 | 145.51 |
| October 05, 2026 | 144.21 |
| October 02, 2026 | 143.18 |
| October 01, 2026 | 140.71 |
| September 30, 2026 | 141.84 |
| Date | Value |
|---|---|
| September 29, 2026 | 138.35 |
| September 28, 2026 | 140.44 |
| September 25, 2026 | 138.40 |
| September 24, 2026 | 138.94 |
| September 23, 2026 | 139.49 |
| September 22, 2026 | 142.25 |
| September 21, 2026 | 143.96 |
| September 18, 2026 | 146.23 |
| September 17, 2026 | 151.83 |
| September 16, 2026 | 149.50 |
| September 15, 2026 | 150.02 |
| September 14, 2026 | 157.22 |
| September 11, 2026 | 156.22 |
| September 10, 2026 | 156.57 |
| September 09, 2026 | 155.14 |
| September 08, 2026 | 155.13 |
| September 04, 2026 | 155.64 |
| September 03, 2026 | 158.35 |
| September 02, 2026 | 157.79 |
| September 01, 2026 | 156.76 |
| August 31, 2026 | 154.03 |
| August 28, 2026 | 154.06 |
| August 27, 2026 | 155.92 |
| August 26, 2026 | 156.59 |
| August 25, 2026 | 153.37 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Amgen, Inc. | 478.34 |
| Halozyme Therapeutics, Inc. | 130.35 |
| BioCryst Pharmaceuticals, Inc. | 8.26 |
| Precigen, Inc. | 5.065 |
| BioMarin Pharmaceutical, Inc. | 57.13 |